Related Experiment Video
Updated: May 19, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Transcriptional activation of the human CD2AP promoter by E2F1
1Department of Pediatrics, The First Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China.
Abstract:
CD2-associated protein (CD2AP) is an adaptor molecule involved in T cell receptor signaling and podocyte homeostasis. CD2AP-deficient mice develop nephritic syndrome and renal failure caused by glomerulosclerosis. Transcription factor E2F1 is a key regulator of cell proliferation and apoptosis. Here we report that E2F1 up-regulates the human CD2AP promoter and further increases the mRNA and protein levels of the human CD2AP in human embryonic kidney (HEK) 293 cells. By semi-quantitative RT-PCR and Western blot analysis we demonstrate that ectopic expression of E2F1 elevates the mRNA and protein levels of CD2AP. Consistently, transient transfection assays prove that overexpression of E2F1 transactivates the CD2AP promoter while knocking-down of endogenous E2F1 by a shRNA strategy results in reduction of the CD2AP promoter activity. Toward understanding the underlying mechanism of this regulation, we performed chromatin immunoprecipitation and mutations of the putative Sp1 binding sites, demonstrating that E2F1 can bind to Sp1 binding site and overexpression of E2F1 is capable of increasing the binding of E2F1 and decreasing the binding of Sp1 to Sp1 binding sites.
Insights
Transcription factor E2F1 enhances CD2-associated protein (CD2AP) expression by up-regulating its promoter activity. This study reveals a novel regulatory mechanism for CD2AP, crucial for kidney function and T cell signaling.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- CD2-associated protein (CD2AP) is vital for T cell receptor signaling and maintaining podocyte health.
- Dysfunction in CD2AP leads to nephritic syndrome and glomerulosclerosis.
- E2F1 is a critical transcription factor regulating cell proliferation and apoptosis.
Purpose of the Study:
- To investigate the regulatory role of transcription factor E2F1 on the CD2AP gene.
- To elucidate the molecular mechanism by which E2F1 influences CD2AP expression.
Main Methods:
- Semi-quantitative RT-PCR and Western blot analysis to assess CD2AP mRNA and protein levels.
- Transient transfection assays to evaluate CD2AP promoter activity.
- Chromatin immunoprecipitation and Sp1 binding site mutation analysis to determine E2F1 binding interactions.
Main Results:
- Ectopic expression of E2F1 significantly increased CD2AP mRNA and protein levels.
- E2F1 overexpression transactivated the human CD2AP promoter.
- Knockdown of E2F1 reduced CD2AP promoter activity.
- E2F1 binds to Sp1 binding sites, modulating E2F1 and Sp1 binding dynamics.
Conclusions:
- E2F1 acts as a positive regulator of CD2AP expression.
- E2F1 up-regulates the CD2AP promoter, potentially through interaction with Sp1 binding sites.
- This finding provides new insights into the transcriptional control of CD2AP, relevant to kidney disease and immune responses.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
Master Transcription Regulators
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Cell Specific Gene Expression

